Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Schmalzing

Showing results (21-30 of 136) with videos related to

Pageof 14
Sort By:
Arthritis Research & Therapy|August 11, 2020
Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantationMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
Arthritis Research & Therapy|May 1, 2019
Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine patternMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
The Open Rheumatology Journal|September 28, 2018
Tocilizumab in Large Vessel Vasculitis - Different Routes of AdministrationMarc Schmalzing, Ottar Gadeholt, Michael Gernert, et al.
Annals of the Rheumatic Diseases|August 30, 2020
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian <i>et al</i>Quirin Notz, Patrick Meybohm, Peter Kranke, et al.
Advances in Rheumatology (London, England)|July 31, 2023
Mesenchymal stem cells modulate IL-17 and IL-9 production induced by Th17-inducing cytokine conditions in autoimmune arthritis: an explorative analysisMaximilian Riekert, Giovanni Almanzar, Marc Schmalzing, et al.
Rheumatology (Oxford, England)|May 21, 2019
Tofacitinib modulates the VZV-specific CD4+ T cell immune response in vitro in lymphocytes of patients with rheumatoid arthritisGiovanni Almanzar, Felix Kienle, Marc Schmalzing, et al.
Arthritis Research & Therapy|April 19, 2015
CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritisZafar Mahmood, Khalid Muhammad, Marc Schmalzing, et al.
Clinical Case Reports|November 18, 2022
CMR detects extensive intracavitary thrombi as solitary clinical presentation of Antiphospholipid Syndrome: A case reportTheresa Reiter, Senem Demirbas, Marc Schmalzing, et al.
Frontiers in Immunology|May 17, 2021
Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine ConditionsJana Heim, Giovanni Almanzar, Marc Schmalzing, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Sophia Mohme, Marc Schmalzing, Cornelia S L Müller, et al.
Pageof 14

Showing results (21-30 of 136) with videos related to

Sort By:
Pageof 14
Arthritis Research & Therapy|August 11, 2020
Low B cell counts as risk factor for infectious complications in systemic sclerosis after autologous hematopoietic stem cell transplantationMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
Arthritis Research & Therapy|May 1, 2019
Autologous hematopoietic stem cell transplantation in systemic sclerosis induces long-lasting changes in B cell homeostasis toward an anti-inflammatory B cell cytokine patternMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
The Open Rheumatology Journal|September 28, 2018
Tocilizumab in Large Vessel Vasculitis - Different Routes of AdministrationMarc Schmalzing, Ottar Gadeholt, Michael Gernert, et al.
Annals of the Rheumatic Diseases|August 30, 2020
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian <i>et al</i>Quirin Notz, Patrick Meybohm, Peter Kranke, et al.
Advances in Rheumatology (London, England)|July 31, 2023
Mesenchymal stem cells modulate IL-17 and IL-9 production induced by Th17-inducing cytokine conditions in autoimmune arthritis: an explorative analysisMaximilian Riekert, Giovanni Almanzar, Marc Schmalzing, et al.
Rheumatology (Oxford, England)|May 21, 2019
Tofacitinib modulates the VZV-specific CD4+ T cell immune response in vitro in lymphocytes of patients with rheumatoid arthritisGiovanni Almanzar, Felix Kienle, Marc Schmalzing, et al.
Arthritis Research & Therapy|April 19, 2015
CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritisZafar Mahmood, Khalid Muhammad, Marc Schmalzing, et al.
Clinical Case Reports|November 18, 2022
CMR detects extensive intracavitary thrombi as solitary clinical presentation of Antiphospholipid Syndrome: A case reportTheresa Reiter, Senem Demirbas, Marc Schmalzing, et al.
Frontiers in Immunology|May 17, 2021
Induction of IL-9 in Peripheral Lymphocytes of Rheumatoid Arthritis Patients and Healthy Donors by Th17-Inducing Cytokine ConditionsJana Heim, Giovanni Almanzar, Marc Schmalzing, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 27, 2020
Sophia Mohme, Marc Schmalzing, Cornelia S L Müller, et al.
Pageof 14